Literature DB >> 15001246

Analysis of serial CT scans to assess template and catheter movement in prostate HDR brachytherapy.

Eduard Mullokandov1, Glen Gejerman.   

Abstract

PURPOSE: As prostate high-dose-rate (HDR) brachytherapy becomes more prevalent, varying amounts of catheter displacement have been noted. To investigate the constancy of catheter position and its impact on dose distribution, we analyzed serial dosimetric CT scans. METHODS AND MATERIALS: The data from 50 patients were analyzed. During initial CT treatment planning, transverse images of the implant volume were collected, and all structures were digitized into the Nucletron Brachytherapy Planning System. Digitally reconstructed radiographs were generated with rendering of the catheter tips, ischial tuberosity, and perineal template. The distance from each catheter tip to the template and to the ischial tuberosity was measured. The distance between the ischial tuberosity and the template was similarly measured. A second CT set was obtained at different intervals and compared with the first measurement to assess catheter and/or template movement. In 10 patients, the second CT set was obtained before the third fraction in both 2-mm and 5-mm slice sequences, and the latter was used to re-create the HDR plan.
RESULTS: Although no interfraction catheter movement relative to the template was found, the template-catheter unit moved in a caudal direction between HDR fractions. The amount of displacement was time dependent: 2 mm before the second fraction, 8 mm before the third, and 10 mm before the fourth. When comparing the first HDR treatment with the third, median decreases in the following dosimetric parameters were noted: dose to 90% of the prostate volume, 35% (r = 0-60); minimal dose to the base, 35% (r = 17-65); and maximal dose to 1 cm(3), 13% (r = 3-19%).
CONCLUSION: The interstitial catheters did not slip within the template and were not caudally displaced independently but rather in conjunction with the template. The displacement occurred in a time-dependent fashion, and, without redress, significant dosimetric changes are encountered by the third fraction.

Entities:  

Mesh:

Year:  2004        PMID: 15001246     DOI: 10.1016/j.ijrobp.2003.08.020

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  13 in total

Review 1.  A review of the clinical experience in pulsed dose rate brachytherapy.

Authors:  Brian V Balgobind; Kees Koedooder; Diego Ordoñez Zúñiga; Raquel Dávila Fajardo; Coen R N Rasch; Bradley R Pieters
Journal:  Br J Radiol       Date:  2015-08-20       Impact factor: 3.039

Review 2.  Management of the complications of external beam radiotherapy and brachytherapy.

Authors:  Stacy Loeb; Robert B Nadler
Journal:  Curr Urol Rep       Date:  2006-05       Impact factor: 3.092

3.  Phase II trial of combined high-dose-rate brachytherapy and external beam radiotherapy for adenocarcinoma of the prostate: preliminary results of RTOG 0321.

Authors:  I-Chow Hsu; Kyounghwa Bae; Katsuto Shinohara; Jean Pouliot; James Purdy; Geoffrey Ibbott; Joycelyn Speight; Eric Vigneault; Robert Ivker; Howard Sandler
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-06       Impact factor: 7.038

4.  Intraoperative 360-deg three-dimensional transvaginal ultrasound during needle insertions for high-dose-rate transperineal interstitial gynecologic brachytherapy of vaginal tumors.

Authors:  Jessica Robin Rodgers; Jeffrey Bax; Kathleen Surry; Vikram Velker; Eric Leung; David D'Souza; Aaron Fenster
Journal:  J Med Imaging (Bellingham)       Date:  2019-04-08

5.  The impact of prostate volume changes during external-beam irradiation in consequence of HDR brachytherapy in prostate cancer treatment.

Authors:  Markus Karl Alfred Herrmann; Tammo Gsänger; Arne Strauss; Tereza Kertesz; Hendrik A Wolff; Hans Christiansen; Hilke Vorwerk; Clemens Friedrich Hess; Andrea Hille
Journal:  Strahlenther Onkol       Date:  2009-06-09       Impact factor: 3.621

6.  High-dose-rate interstitial brachytherapy for gynecologic malignancies--dosimetric changes during treatment period.

Authors:  Tsuyoshi Onoe; Takayuki Nose; Hideomi Yamashita; Minoru Yoshioka; Takashi Toshiyasu; Takuyo Kozuka; Masahiko Oguchi; Keiichi Nakagawa
Journal:  J Radiat Res       Date:  2013-01-07       Impact factor: 2.724

Review 7.  Review of advanced catheter technologies in radiation oncology brachytherapy procedures.

Authors:  Jun Zhou; Leonid Zamdborg; Evelyn Sebastian
Journal:  Cancer Manag Res       Date:  2015-07-16       Impact factor: 3.989

Review 8.  The emerging role of high-dose-rate (HDR) brachytherapy as monotherapy for prostate cancer.

Authors:  Yasuo Yoshioka; Ken Yoshida; Hideya Yamazaki; Norio Nonomura; Kazuhiko Ogawa
Journal:  J Radiat Res       Date:  2013-03-29       Impact factor: 2.724

9.  Effect of using different U/S probe Standoff materials in image geometry for interventional procedures: the example of prostate.

Authors:  Stefanos Diamantopoulos; Natasa Milickovic; Saeed Butt; Zaira Katsilieri; Vasiliki Kefala; Pawel Zogal; George Sakas; Dimos Baltas
Journal:  J Contemp Brachytherapy       Date:  2011-12-30

Review 10.  Review of clinical brachytherapy uncertainties: analysis guidelines of GEC-ESTRO and the AAPM.

Authors:  Christian Kirisits; Mark J Rivard; Dimos Baltas; Facundo Ballester; Marisol De Brabandere; Rob van der Laarse; Yury Niatsetski; Panagiotis Papagiannis; Taran Paulsen Hellebust; Jose Perez-Calatayud; Kari Tanderup; Jack L M Venselaar; Frank-André Siebert
Journal:  Radiother Oncol       Date:  2013-11-30       Impact factor: 6.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.